RAC 1.11% $1.83 race oncology ltd

RAC media coverage, page-720

  1. 2,664 Posts.
    lightbulb Created with Sketch. 3252
    Considering the recent discoveries; it would be a lot easier for a small company like RAC to commercialise an Anthracyclene/Decitabine/PD1 synergiser than a stand alone salvage chemotherapeutic or FTO inhibitor.

    I still think we're gone shortly after any positive readouts in the EM AML/MDS trial (registered as a liquid tumour agent/Decitabine synergiser - not just one cancer indication).
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83
Change
0.020(1.11%)
Mkt cap ! $310.7M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.